Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Quince Therapeutics ( (QNCX) ) has provided an update.
On March 27, 2026, Quince Therapeutics paid approximately $5.5 million to the European Investment Bank to fully settle about $16.4 million in outstanding debt tied to a 2020 finance contract and related guarantees. The company announced on March 30, 2026, that this payment discharged all obligations under the loan and settlement agreements, eliminating a major liability overhang.
Management said the resolution of the EIB debt is a meaningful step in Quince’s ongoing restructuring and review of strategic options intended to enhance shareholder returns. By removing this debt burden, the company believes it has greater financial flexibility to pursue transactions such as mergers, reverse mergers, asset sales, or other strategic deals that could reshape its future direction.
The most recent analyst rating on (QNCX) stock is a Sell with a $0.26 price target. To see the full list of analyst forecasts on Quince Therapeutics stock, see the QNCX Stock Forecast page.
Spark’s Take on QNCX Stock
According to Spark, TipRanks’ AI Analyst, QNCX is a Underperform.
The score is driven primarily by very weak financial performance (no revenue, large losses, sustained cash burn, and a significantly weakened equity position with higher leverage). Technicals also weigh on the score due to a strong downtrend, while valuation is constrained by negative earnings and no dividend support.
To see Spark’s full report on QNCX stock, click here.
More about Quince Therapeutics
Quince Therapeutics, Inc. is a publicly traded company listed on Nasdaq under the ticker QNCX that is currently undergoing a corporate restructuring. The firm is focused on evaluating strategic alternatives, including potential mergers, reverse mergers, asset sales, or other strategic transactions, with the stated aim of maximizing shareholder value.
Average Trading Volume: 66,993,756
Technical Sentiment Signal: Sell
Current Market Cap: $4.88M
For an in-depth examination of QNCX stock, go to TipRanks’ Overview page.